Trying This At Home: Bioxcel Steps Closer To An SNDA For Igalmi BioWorld Insider podcast

Over 20 million podcasts, powered by

Content provided by BioWorld Insider Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BioWorld Insider Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

BioWorld Insider Podcast »
Trying this at home: Bioxcel steps closer to an sNDA for Igalmi

5d ago 9:28

MP3

Bioxcel Therapeutics Inc.’s phase III results in bipolar disorders or schizophrenia could bring Igalmi (BXCL-501) out of the clinic and into patients' homes for easier treatment. Vimal Mehta, Bioxcel CEO, talks about the potential with Lee Landenberger in the latest BioWorld Insider podcast. Watch the video version of this podcast here. Download transcript

50 episodes

Trying this at home: Bioxcel steps closer to an sNDA for Igalmi

BioWorld Insider Podcast

published 5d ago

MP3

50 episodes

All episodes

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.